{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T12:15:20Z","timestamp":1774527320116,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,14]],"date-time":"2015-12-14T00:00:00Z","timestamp":1450051200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ebiomedicine.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EBioMedicine"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.ebiom.2015.12.016","type":"journal-article","created":{"date-parts":[[2015,12,19]],"date-time":"2015-12-19T00:25:24Z","timestamp":1450484724000},"page":"180-190","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Research Investments in Global Health: A Systematic Analysis of UK Infectious Disease Research Funding and Global Health Metrics, 1997\u20132013"],"prefix":"10.1016","volume":"3","author":[{"given":"Michael G.","family":"Head","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph R.","family":"Fitchett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vaitehi","family":"Nageshwaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Hayward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rifat","family":"Atun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2015.12.016_bb0005","unstructured":"Anon. UK 5 Year Antimicrobial Resistance Strategy 2013 to 2018 - Publications \u2014 GOV.UK. (https:\/\/www.gov.uk\/government\/publications\/uk-5-year-antimicrobial-resistance-strategy-2013-to-2018)."},{"key":"10.1016\/j.ebiom.2015.12.016_bb0010","unstructured":"Anon. Threat report 2013 | Antimicrobial Resistance | CDC. (http:\/\/www.cdc.gov\/drugresistance\/threat-report-2013\/ (accessed Oct 14, 2013)."},{"key":"10.1016\/j.ebiom.2015.12.016_bb0015","unstructured":"Anon. The review on antimicrobial resistance. Antimicrobial resistance: tackling a crisis for the future health and wealth of nations. London, 2014 http:\/\/amr-review.org\/Publications (accessed Jan 8, 2015)."},{"key":"10.1016\/j.ebiom.2015.12.016_bb0020","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013","author":"Anon.","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2015.12.016_bb0025","first-page":"ED000057","article-title":"It's time for alltrials registered and reported","volume":"4","author":"Brown","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ebiom.2015.12.016_bb0030","author":"European Commission"},{"key":"10.1016\/j.ebiom.2015.12.016_bb0035","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1371\/journal.pmed.0050022","article-title":"Market failure and the poverty of new drugs in maternal health","volume":"5","author":"Fisk","year":"2008","journal-title":"PLoS Med."},{"key":"10.1016\/j.ebiom.2015.12.016_bb0040","doi-asserted-by":"crossref","DOI":"10.1177\/2054270414538954","article-title":"Investing in sepsis research: systematic analysis of UK public and philanthropic funding 1997\u20132010","volume":"5","author":"Fitchett","year":"2014","journal-title":"JRSM Open"},{"key":"10.1016\/j.ebiom.2015.12.016_bb0045","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/inthealth\/iht036","article-title":"Infectious disease research investments follow colonial ties: questionable ethics","volume":"6","author":"Fitchett","year":"2014","journal-title":"Int. Health"},{"key":"10.1016\/j.ebiom.2015.12.016_bb0050","doi-asserted-by":"crossref","first-page":"e105722","DOI":"10.1371\/journal.pone.0105722","article-title":"Funding infectious disease research: a systematic analysis of UK research investments by funders 1997\u20132010","volume":"9","author":"Fitchett","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ebiom.2015.12.016_bb0055","doi-asserted-by":"crossref","first-page":"5930","DOI":"10.1016\/j.vaccine.2013.10.048","article-title":"Infectious disease research investments: systematic analysis of immunology and vaccine research funding in the UK","volume":"31","author":"Fitchett","year":"2013","journal-title":"Vaccine"},{"issue":"Suppl. 1","key":"10.1016\/j.ebiom.2015.12.016_bb0060","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1038\/embor.2008.110","article-title":"Pricing infectious disease. The economic and health implications of infectious diseases","volume":"9","author":"Fonkwo","year":"2008","journal-title":"EMBO Rep."},{"key":"10.1016\/j.ebiom.2015.12.016_bb0065","first-page":"117","article-title":"Global, regional, and national age\u2013sex specific all-cause and cause-specific mortality for 240 causes of death, 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"385","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2015.12.016_bb0070","doi-asserted-by":"crossref","first-page":"e16837","DOI":"10.1371\/journal.pone.0016837","article-title":"NIH disease funding levels and burden of disease","volume":"6","author":"Gillum","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ebiom.2015.12.016_bb0075","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1177\/0141076813511450","article-title":"Systematic analysis of funding awarded for norovirus research to institutions in the United Kingdom, 1997\u20132010","volume":"107","author":"Head","year":"2014","journal-title":"J. R. Soc. Med."},{"key":"10.1016\/j.ebiom.2015.12.016_bb0080","doi-asserted-by":"crossref","first-page":"e004129","DOI":"10.1136\/bmjopen-2013-004129","article-title":"Systematic analysis of funding awarded for mycology research to institutions in the UK, 1997\u20132010","volume":"4","author":"Head","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/j.ebiom.2015.12.016_bb0085","doi-asserted-by":"crossref","first-page":"e004600","DOI":"10.1136\/bmjopen-2013-004600","article-title":"Investments in respiratory infectious disease research 1997\u20132010: a systematic analysis of UK funding","volume":"4","author":"Head","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/j.ebiom.2015.12.016_bb0090","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1093\/jac\/dkt349","article-title":"Systematic analysis of funding awarded for antimicrobial resistance research to institutions in the UK, 1997\u20132010","volume":"69","author":"Head","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ebiom.2015.12.016_bb0095","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jhin.2014.03.008","article-title":"Funding healthcare-associated infection research: a systematic analysis of UK research investments, 1997\u20132010","volume":"87","author":"Head","year":"2014","journal-title":"J. Hosp. Infect."},{"key":"10.1016\/j.ebiom.2015.12.016_bb0100","doi-asserted-by":"crossref","DOI":"10.1177\/2054270415577056","article-title":"Systematic analysis of funding awarded to institutions in the United Kingdom for infectious disease research, 1997\u20132010","volume":"6","author":"Head","year":"2015","journal-title":"JRSM Open"},{"issue":"9","key":"10.1016\/j.ebiom.2015.12.016_bb0105","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.ebiom.2015.06.024","article-title":"Mapping pneumonia research: a systematic analysis of UK investments and published outputs 1997\u20132013","volume":"2","author":"Head","year":"2015","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ebiom.2015.12.016_bb0110","doi-asserted-by":"crossref","first-page":"020405","DOI":"10.7189\/jogh.05.020405","article-title":"Investments in sexually transmitted infection research, 1997\u20132013: a systematic analysis of funding awarded to UK institutions","volume":"5","author":"Head","year":"2015","journal-title":"J. Glob. Health"},{"key":"10.1016\/j.ebiom.2015.12.016_bb0115","article-title":"Systematic analysis of funding awarded for viral hepatitis-related research to institutions in the United Kingdom, 1997\u20132010","author":"Head","year":"2014","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.ebiom.2015.12.016_bb0120","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1473-3099(12)70261-X","article-title":"UK investments in global infectious disease research 1997\u20132010: a case study","volume":"13","author":"Head","year":"2013","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ebiom.2015.12.016_bb0125","series-title":"News stories","article-title":"Chancellor George Osborne and Bill Gates to join forces to end malaria","author":"HM Treasury D for ID","year":"2015"},{"key":"10.1016\/j.ebiom.2015.12.016_bb0130","first-page":"1050","article-title":"Progress toward global eradication of dracunculiasis\u2014January 2013\u2013June 2014","volume":"63","author":"Hopkins","year":"2014","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.ebiom.2015.12.016_bb0135","author":"Infectious Disease Research Network"},{"key":"10.1016\/j.ebiom.2015.12.016_bb0140","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1478-4505-12-64","article-title":"Are the Norwegian health research investments in line with the disease burden?","volume":"12","author":"Kinge","year":"2014","journal-title":"Health Res. Policy Syst."},{"key":"10.1016\/j.ebiom.2015.12.016_bb0145","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","article-title":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010","author":"Lozano","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2015.12.016_bb1000","doi-asserted-by":"crossref","first-page":"648","DOI":"10.5694\/j.1326-5377.2009.tb03365.x","article-title":"Rational allocation of Australia's research dollars: does the distribution of NHMRC funding by National Health Priority Area reflect actual disease burden?","volume":"191","author":"Mitchell","year":"2009","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.ebiom.2015.12.016_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(15)61340-X","article-title":"Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990\u20132013: quantifying the epidemiological transition","author":"Murray","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2015.12.016_bb0160","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0140-6736(12)61689-4","article-title":"Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990\u20132010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Murray","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2015.12.016_bb0165","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1478-4505-8-36","article-title":"A checklist for health research priority setting: nine common themes of good practice","volume":"8","author":"Viergever","year":"2010","journal-title":"Health Res. Policy Syst."},{"key":"10.1016\/j.ebiom.2015.12.016_bb0170","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/S0140-6736(12)61729-2","article-title":"Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990\u20132010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Vos","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2015.12.016_bb0175","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0168-8510(98)00003-7","article-title":"SOUNDING BOARD","volume":"43","author":"Wiseman","year":"1998","journal-title":"Health Policy (N. Y.)"},{"key":"10.1016\/j.ebiom.2015.12.016_bb0180","series-title":"Antimicrobial Resistance: Global Report on Surveillance 2014","author":"World Health Organization","year":"2014"}],"container-title":["EBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396415302449?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396415302449?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,13]],"date-time":"2020-09-13T00:05:56Z","timestamp":1599955556000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396415302449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":36,"alternative-id":["S2352396415302449"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2015.12.016","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Research Investments in Global Health: A Systematic Analysis of UK Infectious Disease Research Funding and Global Health Metrics, 1997\u20132013","name":"articletitle","label":"Article Title"},{"value":"EBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2015.12.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}